Table 2 Additional characteristics of the advanced bladder cancer cohort, used for adjusting to multivariate Cox-regression
Histological variant (n) | |
|---|---|
Common urothelial carcinoma | 201 |
Plasmocytoid urothelial carcinoma | 17 |
Micropapillary urothelial carcinoma | 10 |
n.a. | 8 |
Type of adjuvant chemotherapy (n) | |
Gemcitabine-cisplatin | 55 |
Mono gemcitabine | 37 |
MVEC | 64 |
Cisplatin-methotrexate | 74 |
n.a. | 6 |
Lymph-node invasion (n) | |
pN0 | 98 |
pN1 | 45 |
pN2 | 70 |
pN3 | 1 |
n.a. | 22 |
P53 expression (n) | |
< 5% | 85 |
≥ 5% | 133 |
n.a. | 18 |